Canadian Peptides: GHK-Cu (Copper Tripeptide) in Preclinical Research

What Is GHK-Cu? A Compound Overview

GHK-Cu is a tripeptide with the amino acid sequence Gly-His-Lys, which demonstrates a high affinity for copper(II) ions. The complex was first identified in 1973 by Loren Pickart, who observed that human albumin fractions could stimulate liver tissue regeneration in animal assays. Subsequent isolation identified the active tripeptide component and revealed its copper-chelating properties, which have since been linked to several proposed mechanisms of biological activity in preclinical experimental settings.

The compound is endogenous in humans, found in plasma, saliva, and urine, with plasma concentrations that have been observed to decline with age in animal aging studies — a characteristic that has driven research interest in its potential role in age-related biological processes. GHK-Cu has been studied across a range of in vitro and in vivo models, including skin fibroblast cultures, wound healing assays in rodents, and gene expression profiling experiments using microarray technology.

Mechanism of Action in Preclinical Models

Preclinical research has proposed several pathways through which GHK-Cu may exert its observed biological effects in laboratory models. Pickart and Margolina (2018) analyzed large-scale gene expression data from GHK-treated cell cultures and found that GHK-Cu appeared to influence the transcription of over 4,000 human genes when applied at physiological concentrations, with apparent upregulation of genes associated with tissue remodeling and downregulation of genes associated with inflammation and oxidative stress markers.

In earlier work, Pickart, Vasquez-Soltero, and Margolina (2015) summarized preclinical findings related to GHK-Cu activity in skin-relevant in vitro models. The review detailed observations of increased collagen and elastin synthesis in fibroblast cultures, apparent activation of matrix metalloproteinase (MMP) pathways involved in extracellular matrix turnover, and stimulation of glycosaminoglycan production in cell-based assays. The authors noted that GHK-Cu's copper(II) coordination chemistry appeared central to many of its observed effects.

What to Look for in a Canadian Peptide Supplier

• HPLC Identity and Purity Testing: Results should reflect actual chromatographic runs, not interpolated estimates.
• Endotoxin Screening: LAL testing on a per-batch basis and documented in the Certificate of Analysis.
• Third-Party Certification: A Certificate of Analysis carries value only when it originates from an independent laboratory.
• Domestic Supply and Cold Chain Integrity: Lyophilized material should be shipped with appropriate temperature control.

ACCUTIDE Research Supply: Analytical Standards

ACCUTIDE Research Supply provides research-grade peptides to investigators across Canada, with all products independently tested by a third-party laboratory. Every batch undergoes HPLC purity and identity analysis, LAL endotoxin screening, and is accompanied by a batch-specific Certificate of Analysis documenting lot number, purity percentage, and endotoxin pass/fail status prior to shipment.